In particular, IKKε was shown to induce breast cancer via mechanisms involving CYLD (Hutti et al, 2009) and TRAF2 (Zhou et al, 2013), ultimately mediating NFκB activation (Boehm et al, 2007). The gene discussed is NFKB1; the disease is breast cancer.